Ribbon’s launches Synthetic MiroSynth Cell-Free DNA product manufactured without bacterial cloning steps. The company has also launched the MiroMine kit, allowing customers to create synthetic DNA constructs in their own labs. Together, these announcements represent a step forward in increasing accessibility to complex DNA. VIENNA — Cell-Free DNA assembly company, Ribbon Bio, has today announced two […]

Round co-led by NfX and Future Ventures will accelerate the build-out of deSIPHR, the nanophotonic chip platform mining the functional layer of biology at scale. PALO ALTO, CA — Pumpkinseed, The Biology Mining Company, today announced a $20 million Series A funding round to scale its protein sequencing platform, mining biological functional data at a resolution […]

Expanded Range Increases Access to Bio-Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the expansion of its TrailBlazer™ StarBright Dye Label Kits, offering a convenient method for […]

Bracco’s new BubbleGen technology streamlines cell therapy manufacturing for one-step cell separation and activation with no magnetic residuals  BubbleGen microbubbles can target specific cell subtypes, including rare populations  Demos available for BubbleGen at ISCT, Booth #2711 Princeton, NJ – Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, unveiled its Early […]

New analysis suite helps cell engineering teams benchmark target identity, detect off-target states, and prioritize protocol improvements ST. LOUIS — CapyBio, a cell identity tools and services company, today announced the launch of three new commercial analysis services: Capybara™ Benchmarking Analysis, Capybara Advanced Analysis, and CellOracle™ Differentiation Optimization Analysis. Together, these services help cell engineering teams […]

IRVINE, Calif. – GeneTex, a multinational recombinant antibody manufacturer, is excited to announce the formalization of a collaborative relationship with the renowned Human Protein Atlas (HPA), a peerless, open-access multi-laboratory organization whose primary goal is to establish a comprehensive map of the human proteome using an integrated omics approach involving antibody-based proteomics and transcriptomics. The HPA’s importance […]

Partnership integrates RoosterBio’s mesenchymal stem cell and extracellular vesicle platforms into Made Scientific’s end-to-end CDMO capabilities to accelerate development and commercial-scale production of advanced therapies PRINCETON, N.J. and FREDERICK, Md. — Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization (CDMO), and RoosterBio, Inc., a leading supplier of human mesenchymal […]

New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical production to support the development of cell therapies for cancer, autoimmune, and other treatments WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built […]

Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA products Complex synthesis capabilities to support further advancement of AI-enabled drug discovery and nucleic acid therapeutics SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, […]

SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. […]